Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Interventional × Anastomotic Leak × Sodium Chloride × Clear all

Phase

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Gastrointestinal 1

Conditions

Breast Neoplasms 32 Neoplasms 11 Pain, Postoperative 10 Colorectal Neoplasms 10 Lung Neoplasms 9 Brain Neoplasms 8 Stomach Neoplasms 7 Prostatic Neoplasms 7 Pancreatic Neoplasms 7 Carcinoma, Non-Small-Cell Lung 7 Melanoma 6 Leukemia, Myeloid, Acute 5 Ovarian Neoplasms 4 Myoma 4 Lymphoma, Non-Hodgkin 4 Leiomyoma 4 Hemorrhage 4 Glioblastoma 4 Colonic Neoplasms 4 Agnosia 4 Skin Neoplasms 3 Recurrence 3 Rectal Neoplasms 3 Precursor Cell Lymphoblastic Leukemia-Lymphoma 3 Neoplasm Metastasis 3 Nasopharyngeal Carcinoma 3 Myelodysplastic Syndromes 3 Hodgkin Disease 3 Head and Neck Neoplasms 3 Fatigue 3

Interventions

Indocyanine Green 2 Ileostomy 2 Water 1 Tobramycin 1 Tissue Adhesives 1 Surgical Procedures, Operative 1 Sodium Chloride 1 Serum Albumin, Human 1 Saline Solution 1 Robotic Surgical Procedures 1 Neomycin 1 Metronidazole 1 Methods 1 Levofloxacin 1 Inulin 1 Fibrin Tissue Adhesive 1 Esophagectomy 1 Enoxaparin 1 Endoscopy 1 Enbucrilate 1 Congresses as Topic 1 Colistin 1 Ciprofloxacin 1 Cathartics 1 Bioseal 1 Amphotericin B 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT02682485 2023-04-26

SES-DTA

University of Chicago

Phase 2 Withdrawn

Gastrointestinal

Rectal Neoplasms, Anastomotic Leak

Data powered by HemOnc (CC BY 4.0) Colophon ⚡